CNET5h
Move Over, mRNA: What to Know About the Novavax COVID Vaccine
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
Is the Novavax COVID-19 Vaccine Better?
While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...
Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...
On the hunt for Novavax: Why people are seeking out the 'traditional' COVID vaccine
Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
Novavax Inc. stock outperforms competitors on strong trading day
Novavax Inc. closed $10.57 below its 52-week high ($23.86), which the company reached on June 6th.
Yahoo5d
On the hunt for Novavax: Why people are seeking out the 'traditional' COVID vaccine
Although Pfizer's and Moderna’s COVID-19 vaccines have been stealing the spotlight for years, some people are actively seeking out the lesser-known Novavax for their updated booster this fall.
Novavax Inc. stock underperforms Monday when compared to competitors
Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.